This inventor holds 1 USPTO granted patent. Top assignee: Hanmi Pharm. Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Euh Lim Oh: Innovator in Respiratory Disease Treatment
Introduction
Euh Lim Oh is a notable inventor based in Hwaseong-si, Gyeonggi-do, South Korea. He has made significant contributions to the field of medicine, particularly in the treatment of respiratory infectious diseases. His innovative approach has led to the development of a unique patent that addresses critical health issues.
Latest Patents
Euh Lim Oh holds a patent titled "Use of Trigonal Agonist Having Activities to All of Glucagon, GLP-1, and GIP Receptors in Treatment of Sequelae Following Respiratory Infectious Diseases." This patent highlights his commitment to advancing medical treatments and improving patient outcomes.
Career Highlights
Euh Lim Oh is currently employed at Hanmi Pharmaceutical Co., Ltd., where he continues to work on groundbreaking research and development projects. His expertise and dedication have positioned him as a key player in the pharmaceutical industry.
Collaborations
Euh Lim Oh collaborates with Jong Suk Lee, a fellow innovator in the field. Together, they work on various projects aimed at enhancing therapeutic options for patients suffering from respiratory conditions.
Conclusion
Euh Lim Oh's contributions to medical innovation, particularly in the treatment of respiratory diseases, underscore his importance in the field. His patent and ongoing work at Hanmi Pharmaceutical Co., Ltd. reflect his dedication to improving health outcomes for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile